Company introduction

    Liaoning Future Health Co., Ltd. (hereinafter referred to as "the Company") established its presence in China Medicine Capital, Benxi, Liaoning in early 2010. Spanning an area of over 360 mu with a total investment exceeding RMB 1 billion, it ranks among China's leading large-scale production bases for antioxidant multi-enzymes.
    In 2012, the Company obtained the Health Food Production License. In 2015, it was granted the Direct Selling Business License by the Ministry of Commerce of the People's Republic of China, marking a solid milestone in making premium products accessible to ordinary households.
    As one of China's top-tier antioxidant multi-enzyme production bases, the Company holds a national invention patent for its independently developed preparation technology of a novel preparation method for superoxide dismutase (SOD) multi-enzyme of maize. Its self-developed and manufactured fully automatic integrated system for seed cleaning, soaking and germination has enabled large-scale production of multi-enzyme extraction, and this core production equipment has also been awarded a national invention patent.
    In 2013, the Company's R&D team was conferred the title of "Worker Pioneer" by the All-China Federation of Trade Unions.